Atlas FDA

SEPRAFILM BIORESORBABLE MEMBRANE

FDA premarket approval P950034/S005 · decided 1998-02-25

Approval details

PMA number
P950034
Supplement
S005
Supplement type
Real-Time Process
Supplement reason
Postapproval Study Protocol
Trade name
SEPRAFILM BIORESORBABLE MEMBRANE
Generic name
Barrier, absorbable, adhesion
Applicant
Baxter Healthcare Corporation
Date received
1997-04-16
Decision date
1998-02-25
Days to decision
315 days
Decision code
APPR
Product code
MCN
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Deerfield Lake, IL
Statement
In this supplment the applicant agrees to submit an Investigational Device Exemptions (IDE) application for the modified postapproval safety study, is approved. We believe that this study, with the modifications as discussed, will satisfy the condition ofapproval for this PMA, but we may have additional comments on the IDE botha s it related to the objectives of the postapproval study, depending on your responses, and your objective of collecting outcomes data on the incidence of small bowel obs

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs) (K251745)Baxter Healthcare Corporation2025-12-16
SIGMA Spectrum Infusion Pump with Master Drug Library (K251640)Baxter Healthcare Corporation2025-07-28
Spectrum IQ Infusion System with Dose IQ Safety Software (3570009) (K251636)Baxter Healthcare Corporation2025-07-28
Solution Administration Sets (K243529)Baxter Healthcare Corporation2025-03-14
Intravascular Extension Sets and Accessories (K242339)Baxter Healthcare Corporation2025-02-28
Novum IQ Syringe Pump (40800BAXUS) (K242390)Baxter Healthcare Corporation2024-09-05
Actifuse ABX; Actifuse MIS; Actifuse Shape; ALTAPORE; ALTAPORE SHAPE; ALTAPORE MIS (K241564)Baxter Healthcare Corporation2024-08-02
Novum IQ Large Volume Pump (K211122)Baxter Healthcare Corporation2024-03-29